US Stock MarketDetailed Quotes

Biofrontera (BFRI)

Watchlist

1.030
-0.010-0.96%

Close Apr 10 16:00 ET

1.060
+0.030+2.91%

Post 20:01 ET

12.00MMarket Cap-0.99P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biofrontera (BFRI) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

11.75%41.71M

36.16%17.1M

-22.46%6.99M

15.19%9.03M

8.54%8.59M

9.54%37.32M

18.53%12.56M

1.30%9.01M

34.05%7.84M

-9.40%7.91M

Operating revenue

11.75%41.71M

36.16%17.1M

-22.46%6.99M

15.19%9.03M

8.54%8.59M

9.54%37.32M

18.53%12.56M

1.30%9.01M

34.05%7.84M

-9.40%7.91M

Cost of revenue

-41.08%10.96M

-42.92%3.01M

-58.07%2.05M

-39.15%2.64M

-20.60%3.27M

6.67%18.61M

-1.79%5.27M

6.25%4.88M

50.35%4.34M

-10.48%4.12M

Gross profit

64.27%30.74M

93.37%14.09M

19.54%4.94M

82.67%6.39M

40.15%5.32M

12.55%18.71M

39.38%7.29M

-3.97%4.14M

18.14%3.5M

-8.20%3.8M

Operating expense

17.16%42.09M

5.92%9.53M

23.38%11.22M

33.84%11.47M

6.52%9.87M

-8.37%35.92M

-1.03%9M

4.23%9.1M

-25.88%8.57M

-5.74%9.26M

Selling and administrative expenses

13.40%38.37M

6.44%8.75M

23.04%10.37M

33.35%10.6M

-6.34%8.66M

-13.53%33.84M

-9.32%8.22M

-3.07%8.43M

-31.18%7.95M

-5.91%9.25M

Research and development costs

78.03%3.72M

0.51%787K

27.65%854K

40.10%870K

7,000.00%1.21M

2,612.99%2.09M

2,272.73%783K

1,927.27%669K

5,545.45%621K

--17K

Operating profit

34.06%-11.35M

366.30%4.56M

-26.57%-6.28M

-0.16%-5.08M

16.83%-4.55M

23.77%-17.21M

55.71%-1.71M

-12.22%-4.96M

41.03%-5.07M

3.95%-5.47M

Net non-operating interest income expense

77.79%-452K

-202.50%-121K

-1,487.50%-111K

80.70%-115K

92.47%-106K

-263.39%-2.04M

86.84%-40K

105.63%8K

-654.43%-596K

-3,920.00%-1.41M

Non-operating interest income

----

0.00%14K

-46.21%71K

-28.57%15K

30.77%17K

-42.86%24K

-75.00%14K

Non-operating interest expense

-77.79%452K

----

-80.70%115K

-91.56%120K

239.17%2.04M

-76.39%55K

-94.19%9K

392.56%596K

1,461.54%1.42M

Total other finance cost

----

1,487.50%111K

----

-55.43%41K

---1.95M

---8K

----

Other net income (expense)

-14.52%1.29M

240.51%1.2M

64.43%-254K

-102.01%-109K

112.61%449K

-50.07%1.51M

-95.41%353K

59.87%-714K

574.24%5.43M

-104.01%-3.56M

Gain on sale of security

-45.92%901K

37.82%481K

58.36%-284K

-97.14%155K

116.00%548K

137.90%1.67M

46.64%349K

57.74%-682K

589.97%5.42M

-79.09%-3.43M

Special income (charges)

--0

-104.26%-316K

--0

-258.00%-316K

-Less：Restructuring and merger&acquisition

----

--0

521.00%621K

--0

-Less:Other special charges

----

104.20%316K

--0

----

--316K

Other non- operating income (expenses)

145.57%388K

17,925.00%721K

193.75%30K

-4,500.00%-264K

-155.00%-99K

5,366.67%158K

105.88%4K

-191.43%-32K

-90.32%6K

645.45%180K

Income before tax

40.74%-10.51M

503.15%5.64M

-17.24%-6.64M

-2,137.55%-5.3M

59.72%-4.2M

11.83%-17.74M

-139.74%-1.4M

10.65%-5.67M

97.59%-237K

-39.65%-10.44M

Income tax

13.64%25K

100.00%6K

5.00%21K

-200.00%-1K

57.14%22K

50.00%-3K

200.00%3K

42.86%20K

-80.00%1K

Net income

40.67%-10.54M

504.01%5.64M

-17.29%-6.65M

-1,971.60%-5.32M

59.73%-4.2M

11.78%-17.76M

-139.59%-1.4M

10.61%-5.67M

97.39%-257K

-39.57%-10.44M

Net income continuous Operations

40.67%-10.54M

504.01%5.64M

-17.29%-6.65M

-1,971.60%-5.32M

59.73%-4.2M

11.78%-17.76M

-139.59%-1.4M

10.61%-5.67M

97.39%-257K

-39.57%-10.44M

Minority interest income

Net income attributable to the parent company

40.67%-10.54M

504.01%5.64M

-17.29%-6.65M

-1,971.60%-5.32M

59.73%-4.2M

11.78%-17.76M

-139.59%-1.4M

10.61%-5.67M

97.39%-257K

-39.57%-10.44M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

40.67%-10.54M

504.01%5.64M

-17.29%-6.65M

-1,971.60%-5.32M

59.73%-4.2M

11.78%-17.76M

-139.59%-1.4M

10.61%-5.67M

97.39%-257K

-39.57%-10.44M

Basic earnings per share

67.70%-1.04

354.84%0.4842

36.73%-0.62

-1,040.00%-0.57

83.68%-0.47

75.27%-3.22

-104.18%-0.19

78.88%-0.98

99.31%-0.05

48.57%-2.88

Diluted earnings per share

67.70%-1.04

354.84%0.4842

36.73%-0.62

-1,040.00%-0.57

83.68%-0.47

75.27%-3.22

-104.18%-0.19

78.88%-0.98

99.31%-0.05

48.57%-2.88

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	11.75%41.71M	36.16%17.1M	-22.46%6.99M	15.19%9.03M	8.54%8.59M	9.54%37.32M	18.53%12.56M	1.30%9.01M	34.05%7.84M	-9.40%7.91M
Operating revenue	11.75%41.71M	36.16%17.1M	-22.46%6.99M	15.19%9.03M	8.54%8.59M	9.54%37.32M	18.53%12.56M	1.30%9.01M	34.05%7.84M	-9.40%7.91M
Cost of revenue	-41.08%10.96M	-42.92%3.01M	-58.07%2.05M	-39.15%2.64M	-20.60%3.27M	6.67%18.61M	-1.79%5.27M	6.25%4.88M	50.35%4.34M	-10.48%4.12M
Gross profit	64.27%30.74M	93.37%14.09M	19.54%4.94M	82.67%6.39M	40.15%5.32M	12.55%18.71M	39.38%7.29M	-3.97%4.14M	18.14%3.5M	-8.20%3.8M
Operating expense	17.16%42.09M	5.92%9.53M	23.38%11.22M	33.84%11.47M	6.52%9.87M	-8.37%35.92M	-1.03%9M	4.23%9.1M	-25.88%8.57M	-5.74%9.26M
Selling and administrative expenses	13.40%38.37M	6.44%8.75M	23.04%10.37M	33.35%10.6M	-6.34%8.66M	-13.53%33.84M	-9.32%8.22M	-3.07%8.43M	-31.18%7.95M	-5.91%9.25M
Research and development costs	78.03%3.72M	0.51%787K	27.65%854K	40.10%870K	7,000.00%1.21M	2,612.99%2.09M	2,272.73%783K	1,927.27%669K	5,545.45%621K	--17K
Operating profit	34.06%-11.35M	366.30%4.56M	-26.57%-6.28M	-0.16%-5.08M	16.83%-4.55M	23.77%-17.21M	55.71%-1.71M	-12.22%-4.96M	41.03%-5.07M	3.95%-5.47M
Net non-operating interest income expense	77.79%-452K	-202.50%-121K	-1,487.50%-111K	80.70%-115K	92.47%-106K	-263.39%-2.04M	86.84%-40K	105.63%8K	-654.43%-596K	-3,920.00%-1.41M
Non-operating interest income	----	----	----	----	0.00%14K	-46.21%71K	-28.57%15K	30.77%17K	-42.86%24K	-75.00%14K
Non-operating interest expense	-77.79%452K	----	----	-80.70%115K	-91.56%120K	239.17%2.04M	-76.39%55K	-94.19%9K	392.56%596K	1,461.54%1.42M
Total other finance cost	----	----	1,487.50%111K	----	----	-55.43%41K	---1.95M	---8K	----	----
Other net income (expense)	-14.52%1.29M	240.51%1.2M	64.43%-254K	-102.01%-109K	112.61%449K	-50.07%1.51M	-95.41%353K	59.87%-714K	574.24%5.43M	-104.01%-3.56M
Gain on sale of security	-45.92%901K	37.82%481K	58.36%-284K	-97.14%155K	116.00%548K	137.90%1.67M	46.64%349K	57.74%-682K	589.97%5.42M	-79.09%-3.43M
Special income (charges)	--0	--0	--0	--0	--0	-104.26%-316K	--0	--0	--0	-258.00%-316K
-Less：Restructuring and merger&acquisition	----	----	----	----	----	--0	--0	--0	521.00%621K	--0
-Less:Other special charges	----	----	----	----	----	104.20%316K	--0	----	----	--316K
Other non- operating income (expenses)	145.57%388K	17,925.00%721K	193.75%30K	-4,500.00%-264K	-155.00%-99K	5,366.67%158K	105.88%4K	-191.43%-32K	-90.32%6K	645.45%180K
Income before tax	40.74%-10.51M	503.15%5.64M	-17.24%-6.64M	-2,137.55%-5.3M	59.72%-4.2M	11.83%-17.74M	-139.74%-1.4M	10.65%-5.67M	97.59%-237K	-39.65%-10.44M
Income tax	13.64%25K	0	100.00%6K	5.00%21K	-200.00%-1K	57.14%22K	50.00%-3K	200.00%3K	42.86%20K	-80.00%1K
Net income	40.67%-10.54M	504.01%5.64M	-17.29%-6.65M	-1,971.60%-5.32M	59.73%-4.2M	11.78%-17.76M	-139.59%-1.4M	10.61%-5.67M	97.39%-257K	-39.57%-10.44M
Net income continuous Operations	40.67%-10.54M	504.01%5.64M	-17.29%-6.65M	-1,971.60%-5.32M	59.73%-4.2M	11.78%-17.76M	-139.59%-1.4M	10.61%-5.67M	97.39%-257K	-39.57%-10.44M
Minority interest income
Net income attributable to the parent company	40.67%-10.54M	504.01%5.64M	-17.29%-6.65M	-1,971.60%-5.32M	59.73%-4.2M	11.78%-17.76M	-139.59%-1.4M	10.61%-5.67M	97.39%-257K	-39.57%-10.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	40.67%-10.54M	504.01%5.64M	-17.29%-6.65M	-1,971.60%-5.32M	59.73%-4.2M	11.78%-17.76M	-139.59%-1.4M	10.61%-5.67M	97.39%-257K	-39.57%-10.44M
Basic earnings per share	67.70%-1.04	354.84%0.4842	36.73%-0.62	-1,040.00%-0.57	83.68%-0.47	75.27%-3.22	-104.18%-0.19	78.88%-0.98	99.31%-0.05	48.57%-2.88
Diluted earnings per share	67.70%-1.04	354.84%0.4842	36.73%-0.62	-1,040.00%-0.57	83.68%-0.47	75.27%-3.22	-104.18%-0.19	78.88%-0.98	99.31%-0.05	48.57%-2.88
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm